{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:58:58Z","timestamp":1791158338489,"version":"4.1.0"},"reference-count":5,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Obesity"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1002\/oby.21094","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T18:40:17Z","timestamp":1429641617000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Safety and tolerability of medications approved for chronic weight management"],"prefix":"10.1002","volume":"23","author":[{"given":"Ken","family":"Fujioka","sequence":"first","affiliation":[{"name":"Division of Diabetes and Endocrinology Scripps Clinic San Diego California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"Xenical (Orlistat) label.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020766s029lbl.pdf. Accessed December 18 2014."},{"key":"e_1_2_12_3_1","unstructured":"Belviq\u00ae (Lorcaserin) label.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022529lbl.pdf. Accessed December 18 2014."},{"key":"e_1_2_12_4_1","unstructured":"Qsymia\u2122 (Phentermine\/topiramate ER) label.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022580s000lbl.pdf. Accessed December 18 2014."},{"key":"e_1_2_12_5_1","unstructured":"Contrave\u00ae (Naltrexone SR\/bupropion SR) label.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/200063s000lbl.pdf. Accessed December 18 2014."},{"key":"e_1_2_12_6_1","unstructured":"Saxenda\u00ae (Liraglutide 3.0 mg label.http:\/\/novo\u2010pi.nnittest.com\/Saxenda\u00ae.pdf. Accessed January 5.2015."}],"container-title":["Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Foby.21094","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Foby.21094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/oby.21094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T02:09:32Z","timestamp":1696039772000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.21094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":5,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1002\/oby.21094"],"URL":"https:\/\/doi.org\/10.1002\/oby.21094","archive":["Portico"],"relation":{},"ISSN":["1930-7381","1930-739X"],"issn-type":[{"value":"1930-7381","type":"print"},{"value":"1930-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"2015-04-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}